OHSU
Healthy Oregon Project Reports at ACMG on Population Genetic Screening Efforts
The project has screened more than 17,000 participants for inherited genetic disorders, particularly hereditary cancer syndromes and familial hypercholesterolemia.
Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test
The collaboration will involve testing 520 samples from pancreatic cancer patients and healthy individuals using the exosome-isolating ExoVita Pancreas assay.
An improved sample prep workflow for single-cell methylation analysis offers the prospect of commercialization, which could be readily taken up in cancer genomics.
Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium
Several institutions, swayed by PGx experts and advocates, are setting up DPYD testing to avoid deadly chemo toxicities in patients even though the NCCN and FDA don't back it.
UW professor Jay Shendure and ex-Illumina R&D maven Frank Steemers have teamed up to commercialize combinatorial indexing-based sequencing assays.